Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Instil Bio, Inc. (TIL)

Instil Bio replaces Deloitte with RSM US as auditor for fiscal 2026

Neutral Impact 2 of 5 other Written later

Instil Bio's Audit Committee dismissed Deloitte & Touche LLP as its independent accounting firm effective April 1, 2026, and appointed RSM US LLP for the fiscal year ending December 31, 2026. The filing states Deloitte's reports on the 2025 and 2024 financial statements contained no adverse opinion, disclaimer, or qualification, and that there were no disagreements or reportable events.

Key points

  • Audit Committee approved RSM US LLP as auditor on April 1, 2026 for fiscal year ending December 31, 2026
  • Deloitte & Touche LLP was dismissed effective April 1, 2026
  • Deloitte's reports for fiscal 2025 and 2024 had no adverse opinion, disclaimer, or qualification
  • Deloitte's letter to the SEC, dated April 3, 2026, is filed as Exhibit 16.1

The filing

CompanyInstil Bio, Inc. (TIL)
Form8-K, current report
Filed with the SECApr 3, 2026, 8:00 AM ET
Accession number0001789769-26-000024

Items reported: 4.01 Auditor Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 03, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.